Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    Ebola and Marburg explained: spread, vaccines and the 2026 outbreak

    Ebola and Marburg viruses both belong to the filovirus family and cause severe, often fatal illness, with average case fatality rates around 50%.[1][2][3] They spread through direct contact with the blood or body fluids of sick or dead people, not through the air, and people are not infectious before symptoms appear.[4] Approved vaccines and treatments exist only for disease caused by one species, Ebola (Zaire) virus; there are none for Marburg, Sudan or Bundibugyo virus.[5][3] A Bundibugyo virus outbreak declared a public health emergency of international concern in May 2026 had reached 10,668 confirmed cases and 5,198 deaths in the DRC by 3 November 2026.[6][7]

    Editor reviewedStrict sourcingUpdated Explainer29 claims · 100% primaryInfectious disease, Health and medicine, World affairs

    This page explains Ebola and Marburg diseases. It is not medical advice. Anyone who develops fever within 21 days of being in an outbreak area or caring for a sick person there should seek medical care and say where they have been. The 2026 outbreak figures change weekly; check WHO’s latest Disease Outbreak News.

    Ebola and Marburg diseases are caused by filoviruses, and the world-health-organization says the two are clinically similar.[1] WHO describes both as rare but capable of causing outbreaks with high fatality rates, and puts the average case fatality rate of each at around 50%.[1][2][3]

    The viruses

    WHO says three viruses are known to cause large Ebola disease outbreaks: Ebola virus, Sudan virus and Bundibugyo virus.[2] Ebola disease first appeared in 1976 in two simultaneous outbreaks, in what are now South Sudan and the Democratic Republic of the Congo, and takes its name from the Ebola River near the Congolese village affected.[8] Fruit bats of the Pteropodidae family are thought to be the natural hosts.[9]

    Marburg disease was first detected in 1967 in Marburg and Frankfurt, Germany, and Belgrade, linked to laboratory work with African green monkeys imported from Uganda.[10] Its natural host is the Egyptian rousette fruit bat, and human infection initially follows prolonged exposure to mines or caves where these bats live.[11] Rwanda had its first Marburg outbreak in 2024, with 66 cases and 15 deaths, and Tanzania declared another in January 2025; the largest on WHO’s list was in Angola in 2005, with 374 cases and 329 deaths.[12] WHO counts 72 Ebola and Marburg outbreaks in Africa since 1967.[13]

    How they spread and what they do

    People catch these viruses through direct contact with the blood or body fluids of someone sick with or who has died from the disease. They cannot pass it on before symptoms appear, and the centers-for-disease-control-and-prevention stresses that Ebola does not spread like flu or COVID.[4] Health workers are often infected when infection control lapses, and burial ceremonies involving contact with the body can spread the disease.[14]

    Symptoms appear 2 to 21 days after infection, starting with fever, fatigue, muscle pain, headache and sore throat, then vomiting and diarrhoea. WHO says bleeding is less common than often believed and tends to come later.[15] The virus can persist in some survivors, in the testicles, eye or brain, and sexual transmission via semen has been documented up to 15 months after recovery.[16]

    Vaccines, treatments and outbreak control

    Approved vaccines and treatments exist only for disease caused by Ebola (Zaire) virus. WHO strongly recommends two monoclonal antibody treatments for it, and two vaccines are approved, Ervebo and Zabdeno/Mvabea.[5] The FDA first approved Ervebo in December 2019, for people 12 months and older.[17] There are no approved vaccines or antiviral treatments for Marburg.[3]

    WHO says early intensive supportive care, including rehydration and treatment of symptoms, improves survival in Ebola disease.[18] In June 2026 WHO issued its first comprehensive clinical guidelines covering all filovirus diseases, with 16 recommendations.[13] Outbreak control relies on safe and dignified burials and on tracing contacts and monitoring them for 21 days.[19]

    The 2026 Bundibugyo outbreak

    In May 2026 the WHO Director-General declared the Bundibugyo virus outbreak in the DRC and Uganda a public health emergency of international concern, while finding that it did not meet the criteria for a “pandemic emergency”.[6] At the time, 8 confirmed cases, 246 suspected cases and 80 suspected deaths had been reported in Ituri Province, plus two confirmed cases in Kampala among travellers from the DRC.[20] See how pandemics are declared for what that status means.

    By 3 November 2026, WHO reported 10,668 confirmed cases in the DRC, including 5,198 deaths (a crude case fatality ratio of 48.7%), across 67 health zones in eight provinces.[7] WHO says it is the largest Ebola disease outbreak ever recorded in the DRC, of any species, and only the country’s second Bundibugyo outbreak, after 2012.[21] The two earlier Bundibugyo outbreaks, in Uganda in 2007 and the DRC in 2012, had case fatality rates of 30% and 50%.[22] Cases have been reported in five countries: the DRC, France, Kenya, Nigeria and Uganda, with the French and Ugandan outbreaks controlled since August.[23] WHO had not published a newer Disease Outbreak News update on the outbreak by 14 November.[24] Africa CDC said on 8 November that health facilities in North Kivu had been attacked after an attack on civilians in Cantine-Aloya on 5 November, reportedly by the Allied Democratic Forces, and that patients, including hundreds with confirmed or suspected Ebola, had fled.[25]

    Because no Bundibugyo-specific products are approved, research is running inside the response. The Tumaini ring-vaccination trial began enrolling in Bunia on 23 October 2026, first testing Ervebo; WHO advisers recommended adding Oxford’s ChAdOx1 and Moderna’s mRNA-1469 candidates, with results expected in early 2027.[26] The PARTNERS trial, launched in July 2026, is testing the monoclonal antibody MBP134 and the antiviral remdesivir.[27]

    CDC says the viruses pose little risk to travellers or the general public, and WHO advises against restricting travel to or trade with affected countries.[28][29]

    World Health Organization (WHO)

    The UN agency for health: how WHO is governed and funded, the US withdrawal that took effect in January 2026, and the Pandemic Agreement's unfinished annex.

    Developing in Health

    Go deeper

    Questions readers ask

    How does Ebola spread?

    Through direct contact with the blood or body fluids of someone who is sick with or has died from Ebola disease, or with contaminated objects. People cannot pass it on before they have symptoms, and CDC says it does not spread like respiratory viruses such as flu and COVID.[4]

    Is there a vaccine for Ebola?

    For disease caused by Ebola (Zaire) virus, yes. Two vaccines are approved, Ervebo and Zabdeno/Mvabea, and the FDA has approved Ervebo for people 12 months and older. WHO says approved vaccines exist only for Ebola virus; vaccines are being tested against Bundibugyo virus in a trial during the 2026 outbreak.[5][17][26]

    What is the difference between Ebola and Marburg?

    They are caused by different viruses in the same filovirus family, and WHO says the diseases are clinically similar. Both have average case fatality rates around 50%. Ebola virus disease has approved vaccines and treatments; Marburg has none.[1][3][2]

    How big is the 2026 Ebola outbreak?

    As of 3 November 2026, WHO reported 10,668 confirmed Bundibugyo virus disease cases and 5,198 deaths in the DRC. WHO calls it the largest Ebola disease outbreak ever recorded in the country. Cases have also been reported in France, Kenya, Nigeria and Uganda.[7][21][23]

    Is Ebola a risk for travellers?

    CDC says the viruses that cause Ebola disease pose little risk to travellers or the general public, and WHO advises against restricting travel to or trade with affected countries.[28][29]

    Sources

    · 29 claims from 4 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      Marburg and Ebola viruses both belong to the filovirus family, and WHO says the two diseases are clinically similar and that both are rare but can cause outbreaks with high fatality rates. confirmedas of 2026-11-07

    2. [2]

      WHO describes Ebola disease as a severe, often fatal illness; three viruses are known to cause large outbreaks, Ebola virus, Sudan virus and Bundibugyo virus, and the average case fatality rate is around 50%. confirmedas of 2026-11-07

    3. [3]

      Marburg virus disease is a severe, often fatal illness with an average case fatality rate around 50%; there are no approved vaccines or antiviral treatments for it. confirmedas of 2026-11-07

    4. [4]

      People spread Ebola through direct contact with blood or body fluids of sick or dead patients; they cannot transmit it before symptoms appear, and CDC says it does not spread like respiratory viruses such as flu and COVID. confirmedas of 2026-11-07

    5. [5]

      Approved vaccines and treatments exist only for disease caused by Ebola virus (Zaire ebolavirus), not Sudan or Bundibugyo virus; WHO strongly recommends two monoclonal antibody treatments, and two vaccines are approved, Ervebo and Zabdeno/Mvabea. confirmedas of 2026-11-07

    6. [6]

      In May 2026 the WHO Director-General determined that the Ebola disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda was a public health emergency of international concern, but did not meet the criteria for a pandemic emergency. confirmedas of 2026-11-07

    7. [7]

      As of 3 November 2026, WHO reported 10,668 confirmed Bundibugyo virus disease cases in the DRC, including 5,198 deaths (a crude case fatality ratio of 48.7%), across 67 health zones in eight provinces. confirmedas of 2026-11-07

    8. [8]

      Ebola disease first appeared in 1976 in two simultaneous outbreaks, in what are now South Sudan and the Democratic Republic of the Congo; the disease is named after the Ebola River, near the Congolese village affected. confirmedas of 2026-11-07

    9. [9]

      WHO says fruit bats of the Pteropodidae family are thought to be the natural hosts of the viruses, which can enter people through close contact with infected animals' blood or body fluids. confirmedas of 2026-11-07

    10. [10]

      Marburg disease was first detected in 1967 in outbreaks in Marburg and Frankfurt, Germany, and Belgrade, linked to laboratory work with African green monkeys imported from Uganda. confirmedas of 2026-11-07

    11. [11]

      The Egyptian rousette fruit bat is the natural host of Marburg virus, and human infection initially follows prolonged exposure to mines or caves inhabited by these bats. confirmedas of 2026-11-07

    12. [12]

      WHO lists Rwanda's first Marburg outbreak in 2024 (66 cases, 15 deaths) and a Tanzanian outbreak declared in January 2025; the largest recorded outbreak was in Angola in 2005, with 374 cases and 329 deaths. confirmedas of 2026-11-07

    13. [13]

      WHO says 72 outbreaks of Ebola and Marburg diseases have been reported in Africa since 1967, and in June 2026 it issued its first comprehensive clinical guidelines covering all filovirus diseases, with 16 recommendations. confirmedas of 2026-11-07

    14. [14]

      WHO says health workers are frequently infected when infection control is not strictly practised, and burial ceremonies involving direct contact with the body can spread the disease. confirmedas of 2026-11-07

    15. [15]

      Ebola symptoms appear 2 to 21 days after infection, starting with fever, fatigue, muscle pain, headache and sore throat and followed by vomiting and diarrhoea; WHO says bleeding is less frequent than often perceived and can occur later. confirmedas of 2026-11-07

    16. [16]

      Ebola virus can persist in some survivors in sites such as the testicles, eye and brain; WHO says sexual transmission via semen has been documented up to 15 months after recovery. confirmedas of 2026-11-07

    17. [17]

      The FDA-approved Ervebo vaccine is indicated to prevent disease caused by Zaire ebolavirus in people 12 months and older; it was first approved in December 2019. confirmedas of 2026-11-07

      • ERVEBO · US Food and Drug Administration · Primary source (retrieved 2026-11-07)
      • ERVEBO · US Food and Drug Administration · Primary source (retrieved 2026-11-07)
    18. [18]

      WHO says early intensive supportive care, including rehydration and treatment of symptoms, improves survival. confirmedas of 2026-11-07

    19. [19]

      Outbreak control includes safe and dignified burials and identifying contacts of infected people and monitoring their health for 21 days. confirmedas of 2026-11-07

    20. [20]

      When the emergency was declared, 8 laboratory-confirmed cases, 246 suspected cases and 80 suspected deaths had been reported in Ituri Province, DRC, as of 16 May 2026, plus two confirmed cases in Kampala, Uganda, among travellers from the DRC. confirmedas of 2026-11-07

    21. [21]

      WHO says the 2026 outbreak is the largest Ebola disease outbreak ever recorded in the DRC, of any virus species, and only the country's second Bundibugyo outbreak after 2012. confirmedas of 2026-11-07

    22. [22]

      The two previous Bundibugyo outbreaks, in Uganda in 2007 and the DRC in 2012, had case fatality rates of 30% and 50%. confirmedas of 2026-11-07

    23. [23]

      WHO says cases have been reported in five countries since the outbreak was declared on 15 May 2026, the DRC, France, Kenya, Nigeria and Uganda, with the outbreaks in France and Uganda controlled since August. confirmedas of 2026-11-07

    24. [24]

      As of 14 November 2026 WHO's newest Disease Outbreak News report on the Bundibugyo Ebola outbreak was the one published on 6 November (2026-DON625); the only report published after it was on MERS in Qatar, on 13 November. confirmedas of 2026-11-14

    25. [25]

      Africa CDC said on 8 November 2026 that an attack on civilians in Cantine-Aloya, North Kivu, on 5 November, reportedly by the Allied Democratic Forces, came at a critical moment in the Ebola response, and that health facilities had been attacked and patients, including hundreds with confirmed or suspected Ebola, had fled. confirmedas of 2026-11-08

    26. [26]

      The Tumaini ring-vaccination trial against Bundibugyo virus began enrolling in Bunia on 23 October 2026, first testing Ervebo; WHO advisers recommended adding Oxford's ChAdOx1 and Moderna's mRNA-1469 candidates, with results expected in early 2027. confirmedas of 2026-11-07

    27. [27]

      The WHO-sponsored PARTNERS trial, launched in July 2026, is testing whether the monoclonal antibody MBP134, the antiviral remdesivir or both improve survival in confirmed Bundibugyo virus disease. confirmedas of 2026-11-07

    28. [28]

      CDC says the viruses that cause Ebola disease pose little risk to travellers or the general public. confirmedas of 2026-11-07

      • About Ebola · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-07)
    29. [29]

      WHO advises against restricting travel to, or trade with, countries affected by the Bundibugyo outbreak. confirmedas of 2026-11-07

    Revision history (2)
    1. Re-checked WHO's outbreak figures (3 November data were still the latest) and added Africa CDC's 8 November statement on attacks on health facilities in North Kivu.
    2. Page created.

    Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Nov 28, 2026.

    Cite this page

    "Ebola and Marburg explained: spread, vaccines and the 2026 outbreak." ContentLora, updated Nov 14, 2026. https://contentlora.com/explain/ebola-and-marburg-explained

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.